Patients who may benefit from evaluation include adults who: Have a BMI of 30 or higher Have a BMI of 27 or higher with weight-related health considerations Are seeking medical guidance for appetite awareness Want structured support alongside nutrition and lifestyle changes Final treatment recommendations are made only after a clinical review of medical history, labs, and current medications
Mahmood has seen marked increased laxity in the tissue of the breasts, abdomen, arms, and medial thighs [the part of the thigh that includes the hips] on patients who have taken a GLP-1 to lose weight
For example, one study found that 14 mg of oral semaglutide per week for 52 weeks resulted in an average of 10 pounds lost
Tirzepatide performs the insulinotropic and gastrointestinal functions as semaglutide, but mirroring GIP also: Stimulates insulin release, and Might have unique synergistic benefits for weight management
10.4155/fmc.13.130 124 LuoZ.XuJ.SunJ.HuangH.ZhangZ.MaW.et al (2020)
